Sensitol
Natural health product licensed in Canada
- Licence holder
- Designs for Health
- NPN or DIN-HM
- 80068212
- Status
- Active licence
- Licence date
- 1 April 2016
- Revision date
- 16 January 2023
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide DL-alpha-lipoïque Source : Acide DL-alpha-lipoÏque | 50 mg | Not calculated |
| Inositol Source : Inositol | 750 mg | Not calculated |
| D-Chiro-inositol Source : D-Chiro-inositol | 50 mg | Not calculated |
Non-medicinal ingredients
Hypromellose, Stéarate de magnésium, Dioxyde de silicium, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 2 Tous les jours |
Uses authorised in Canada
Aids in the management of the symptoms associated with polycystic ovarian syndrome's (PCOS) metabolic features by promoting healthy glucose metabolism. Aids in the management of polycystic ovarian syndrome (PCOS) by helping restore normal ovarian function. Helps to reduce serum testosterone in women with polycystic ovarian syndrome (PCOS). Helps promote normal ovulation in those with polycystic ovarian syndrome (PCOS).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If symptoms persist or worsen, consult your healthcare practitioner. Consult a health care practitioner prior to use if you have diabetes.
- Contre-indications
Do not take if you are pregnant or breastfeeding.
Source
Official Health Canada record, licence 80068212
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2023. Photograph the packaging to check whether it has changed. Photograph the packaging